EU Parliament’s plan to link market exclusivity to unmet need ‘ethically difficult’
Regulatory NewsNick Paul Taylor
Biologics/ biosimilars/ vaccinesEuropePharmaceuticalsProduct developmentProduct LifecycleRegulatory Intelligence/PolicyRegulatory NewsNick Paul TaylorBiologics/ biosimilars/ vaccinesEuropePharmaceuticalsProduct developmentProduct LifecycleRegulatory Intelligence/Policy